Akzo Nobel N.V.
AKZOY
$20.32
-$0.55-2.64%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.76B | 2.98B | 2.98B | 2.75B | 2.79B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.76B | 2.98B | 2.98B | 2.75B | 2.79B |
| Cost of Revenue | 1.67B | 1.78B | 1.80B | 1.65B | 1.70B |
| Gross Profit | 1.09B | 1.20B | 1.18B | 1.10B | 1.09B |
| SG&A Expenses | 615.81M | 906.06M | 928.37M | 891.34M | 635.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -770.63M | 319.17M | -2.27M | 1.05M | 1.07M |
| Total Operating Expenses | 1.84B | 3.00B | 2.73B | 2.54B | 2.65B |
| Operating Income | 925.46M | -24.55M | 251.95M | 210.47M | 141.77M |
| Income Before Tax | 868.42M | -112.23M | 203.15M | 177.85M | 101.27M |
| Income Tax Expenses | 162.97M | 109.90M | 49.94M | 50.51M | 62.89M |
| Earnings from Continuing Operations | 705.44M | -222.13M | 153.22M | 127.33M | 38.37M |
| Earnings from Discontinued Operations | 0.00 | -1.17M | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.31M | -3.51M | -12.48M | -14.73M | -15.99M |
| Net Income | 696.13M | -226.81M | 140.73M | 112.60M | 22.39M |
| EBIT | 925.46M | -24.55M | 251.95M | 210.47M | 141.77M |
| EBITDA | 1.04B | 85.35M | 356.37M | 309.39M | 241.97M |
| EPS Basic | 4.07 | -1.33 | 0.82 | 0.66 | 0.13 |
| Normalized Basic EPS | 3.14 | -0.41 | 0.67 | 0.56 | 0.29 |
| EPS Diluted | 4.06 | -1.33 | 0.82 | 0.65 | 0.13 |
| Normalized Diluted EPS | 3.13 | -0.41 | 0.67 | 0.56 | 0.28 |
| Average Basic Shares Outstanding | 171.10M | 171.00M | 171.00M | 170.80M | 170.80M |
| Average Diluted Shares Outstanding | 171.84M | 171.00M | 171.00M | 172.58M | 175.00M |
| Dividend Per Share | 1.79 | 0.00 | 0.50 | -- | 1.64 |
| Payout Ratio | 6.19% | -13.92% | 216.94% | 5.61% | 247.62% |